research use only
Cat.No.S4538
| Related Targets | CFTR CRM1 CD markers AChR Calcium Channel Sodium Channel Potassium Channel GABA Receptor TRP Channel ATPase |
|---|---|
| Other Proton Pump Inhibitors | Bafilomycin A1 (Baf-A1) Ilaprazole Tenatoprazole Revaprazan Hydrochloride Ilaprazole sodium PF-3716556 Ufiprazole |
| Molecular Weight | 405.35 | Formula | C16H14F2N3NaO4S |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 138786-67-1 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | SKF96022 sodium, BY-1023 sodium | Smiles | COC1=C(C(=NC=C1)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC(F)F)OC.[Na+] | ||
|
In vitro |
DMSO
: 81 mg/mL
(199.82 mM)
Water : 81 mg/mL Ethanol : 81 mg/mL |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Targets/IC50/Ki |
Proton pump
HIF-1α
(H+/K+)-ATPase
|
|---|---|
| In vitro |
pantoprazole (PPZ) inhibits tumour cell proliferation, induces apoptosis and decreases the expression of HIF-1α protein. Pantoprazole affects the intracellular distribution of HIF-1α in SGC-7901 cells, which might be one of the mechanisms of its chemosensitising effect on cancer cells.
|
| In vivo |
After PPZ treatment, apoptotic cell death is seen selectively in cancer cells and is accompanied with extracellular signal-regulated kinase deactivation. By contrast, normal gastric mucosal cells show resistance to PPZ-induced apoptosis through the overexpression of antiapoptotic regulators including HSP70 and HSP27. In a xenograft model of nude mice, administration of PPZ significantly inhibits tumourigenesis and induces large-scale apoptosis of tumour cells.
|
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.